Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease

This publication has 231 references indexed in Scilit:

• The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation
  New England Journal of Medicine, 1999
• Pla1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty
  The American Journal of Cardiology, 1998
• Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives
  British Journal of Haematology, 1997
• Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene
  Human Genetics, 1996
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Prospective study of endogenous tissue plasminogen activator and risk of stroke
  The Lancet, 1994
• Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease
  Atherosclerosis, 1992
• Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion event
  Human Genetics, 1992
• Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
  New England Journal of Medicine, 1984
• .alpha.-Chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspects
  Biochemistry, 1981